Want to see JP:7730 full AI Analyst Report?
Top Page
Mani, Inc.
(7730)
Select Model
Select Model
Rating:70Outperform
Price Target:
¥1,761.00
▲(17.36% Upside)
Action:Reiterated
Date:07/17/26
The score is primarily supported by strong profitability and a very low-risk balance sheet, but is held back by the sharp deterioration in recent free cash flow and softer net margin. Technicals are neutral with near-term weakness versus key moving averages, and valuation is only fair given a ~25 P/E despite a ~2.5% dividend yield.
Positive Factors
Conservative balance sheet
Extremely low leverage and a rising equity base materially reduce solvency and refinancing risk, giving management durable optionality. Over the next 2–6 months this balance sheet supports capital allocation flexibility for M&A, R&D, or sustaining dividends without stressing liquidity.
Negative Factors
Free cash flow compression
A sudden drop in free cash flow limits shareholder-return capacity and internal funding for growth. Even with positive operating cash, volatile FCF suggests heavier capex or working-capital absorption that could constrain dividends, buybacks, or organic expansion over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Extremely low leverage and a rising equity base materially reduce solvency and refinancing risk, giving management durable optionality. Over the next 2–6 months this balance sheet supports capital allocation flexibility for M&A, R&D, or sustaining dividends without stressing liquidity.
Read all positive factors
Mani, Inc. (7730) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥157.73B
Dividend Yield2.73%
Average Volume (3M)283.94K
Price to Earnings (P/E)25.0
Beta (1Y)0.99
Revenue Growth9.94%
EPS Growth10.50%
CountryJP
Employees4,140
SectorGeneral
Sector StrengthN/A
IndustryMedical - Specialties
Share Statistics
EPS (TTM)64.21
Shares Outstanding107,003,280
10 Day Avg. Volume284,170
30 Day Avg. Volume283,943
Financial Highlights & Ratios
PEG Ratio-1.02
Price to Book (P/B)2.31
Price to Sales (P/S)4.12
P/FCF Ratio201.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)74.49
Revenue Forecast (FY)¥33.31B
Mani, Inc. Business Overview & Revenue Model
Company Description
Mani, Inc. engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Pro...
How the Company Makes Money
Mani, Inc. makes money primarily by selling its medical and dental products to customers such as dental clinics, hospitals, and distributors. Revenue is generated from product sales (including recurring sales of consumable instruments that are reg...
Mani, Inc. Financial Statement Overview
Summary
Income Statement
82
Very Positive
Balance Sheet
92
Very Positive
Cash Flow
58
Neutral
| Breakdown | TTM | Aug 2025 | Aug 2024 | Aug 2023 | Aug 2022 | Aug 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.16B | 29.97B | 28.51B | 24.49B | 20.42B | 17.19B |
| Gross Profit | 20.39B | 19.32B | 17.90B | 15.42B | 12.57B | 11.01B |
| EBITDA | 12.03B | 9.56B | 10.70B | 9.94B | 9.17B | 7.55B |
| Net Income | 6.33B | 4.64B | 6.29B | 5.95B | 5.29B | 4.29B |
Balance Sheet | ||||||
| Total Assets | 61.49B | 58.19B | 57.33B | 55.11B | 50.18B | 42.90B |
| Cash, Cash Equivalents and Short-Term Investments | 22.84B | 18.73B | 21.66B | 25.43B | 22.73B | 18.89B |
| Total Debt | 64.00M | 76.00M | 83.00M | 58.00M | 117.00M | 128.00M |
| Total Liabilities | 4.83B | 4.63B | 5.00B | 5.28B | 4.76B | 3.69B |
| Stockholders Equity | 56.66B | 53.56B | 52.33B | 49.83B | 45.41B | 39.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 612.00M | 397.00M | 4.52B | 4.76B | 2.62B |
| Operating Cash Flow | 0.00 | 7.03B | 7.82B | 8.03B | 6.57B | 6.41B |
| Investing Cash Flow | 0.00 | -7.17B | -6.65B | -4.02B | -2.19B | -3.47B |
| Financing Cash Flow | 0.00 | -3.90B | -3.70B | -3.25B | -2.44B | -2.23B |
Mani, Inc. Technical Analysis
Negative
1500.50
Price Trends
1705.36
Negative
1660.19
Negative
1555.88
Positive
Market Momentum
-2.80
Positive
34.44
Neutral
52.43
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7730, the sentiment is Negative. The current price of 1500.5 is below the 20-day moving average (MA) of 1713.95, below the 50-day MA of 1705.36, and below the 200-day MA of 1555.88, indicating a neutral trend. The MACD of -2.80 indicates Positive momentum. The RSI at 34.44 is Neutral, neither overbought nor oversold. The STOCH value of 52.43 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7730.
Mani, Inc. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥78.82B | 16.03 | ― | 2.83% | 3.35% | 13.05% | |
76 Outperform | ¥920.15B | 30.50 | 11.64% | 0.82% | 15.13% | 196.11% | |
70 Outperform | ¥157.73B | 25.03 | ― | 2.73% | 9.94% | 10.50% | |
66 Neutral | ¥1.92T | 28.78 | 11.34% | 1.01% | 1.34% | -40.41% | |
63 Neutral | ¥257.46B | 213.48 | -2.06% | 2.66% | 9.95% | -79.87% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | ¥257.69B | 19.07 | 4.38% | 2.03% | 2.47% | 164.11% |
* General Sector Average
JP:7730
Mani, Inc.
1,601.00
420.46
35.62%
JP:7747
Asahi Intecc Co
3,468.00
1,192.51
52.41%
JP:7716
Nakanishi
3,050.00
1,164.72
61.78%
JP:8086
Nipro
1,580.00
253.96
19.15%
JP:7733
Olympus
1,747.00
61.71
3.66%
JP:7979
Shofu Inc.
2,209.00
263.08
13.52%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.